293 related articles for article (PubMed ID: 22130201)
1. [Therapy in IgA nephropathy--when and how to do it].
Vas T; Kovács T; Késoi I; Sági B; Degrell P; Wittmann I; Nagy J
Orv Hetil; 2011 Dec; 152(51):2039-46. PubMed ID: 22130201
[TBL] [Abstract][Full Text] [Related]
2. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
3. Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
Shima Y; Nakanishi K; Kamei K; Togawa H; Nozu K; Tanaka R; Sasaki S; Iijima K; Yoshikawa N
Nephrol Dial Transplant; 2011 Jan; 26(1):163-9. PubMed ID: 20601366
[TBL] [Abstract][Full Text] [Related]
4. Immune characteristics of renal allograft donors with mesangial IgA deposition.
Wang Z; Zhang X; Han W; Yu G; Ying Z; Xu X; Wang M; Zhou X; Lv J; Zhang H
Int Immunopharmacol; 2021 Feb; 91():107282. PubMed ID: 33370682
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin A1 protease: a new therapeutic candidate for immunoglobulin A nephropathy.
Xie LS; Huang J; Qin W; Fan JM
Nephrology (Carlton); 2010 Aug; 15(5):584-6. PubMed ID: 20649880
[TBL] [Abstract][Full Text] [Related]
6. IgA nephropathy: an update.
Julian BA; Novak J
Curr Opin Nephrol Hypertens; 2004 Mar; 13(2):171-9. PubMed ID: 15202611
[TBL] [Abstract][Full Text] [Related]
7. Role of complement in IgA nephropathy.
Daha MR; van Kooten C
J Nephrol; 2016 Feb; 29(1):1-4. PubMed ID: 26567162
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies in IgA nephropathy.
O'Donoghue DJ; Feehally J
Contrib Nephrol; 1995; 111():93-103; discussion 104-6. PubMed ID: 7758352
[No Abstract] [Full Text] [Related]
9. Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schönlein purpura.
O'Donoghue DJ; Darvill A; Ballardie FW
J Clin Invest; 1991 Nov; 88(5):1522-30. PubMed ID: 1939642
[TBL] [Abstract][Full Text] [Related]
10. Post-transplant immunoglobulin A deposition and nephropathy in allografts.
Sofue T; Suzuki H; Ueda N; Kushida Y; Minamino T
Nephrology (Carlton); 2018 Jul; 23 Suppl 2():4-9. PubMed ID: 29968406
[TBL] [Abstract][Full Text] [Related]
11. Mesangial autoantigens in IgA nephropathy: matrix synthesis and localization.
Darvill AM; Ballardie FW
J Lab Clin Med; 2006 Jun; 147(6):301-9. PubMed ID: 16750668
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
Sato K; Makabe S; Iwabuchi Y; Kojima K; Sato M; Kataoka H; Moriyama T; Taneda S; Tsuchiya K; Nitta K; Mochizuki T
Nephrology (Carlton); 2018 Aug; 23(8):787-790. PubMed ID: 29577510
[TBL] [Abstract][Full Text] [Related]
13. IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy.
Lechner SM; Abbad L; Boedec E; Papista C; Le Stang MB; Moal C; Maillard J; Jamin A; Bex-Coudrat J; Wang Y; Li A; Martini PG; Monteiro RC; Berthelot L
J Am Soc Nephrol; 2016 Sep; 27(9):2622-9. PubMed ID: 26850635
[TBL] [Abstract][Full Text] [Related]
14. Mesangial immunoglobulin A deposition and focal glomerulosclerosis in a renal transplant patient with nephrotic syndrome--Berger's disease alone or superimposition of focal glomerulosclerosis?
Okubo M; Horata-Takahashi E; Tamura K; Kamata K; Kobayashi Y; Nakayama Y; Osakabe T; Sato K; Kumano K; Endo T
Transplant Proc; 1993 Apr; 25(2):2109-12. PubMed ID: 8470287
[No Abstract] [Full Text] [Related]
15. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.
Moldoveanu Z; Wyatt RJ; Lee JY; Tomana M; Julian BA; Mestecky J; Huang WQ; Anreddy SR; Hall S; Hastings MC; Lau KK; Cook WJ; Novak J
Kidney Int; 2007 Jun; 71(11):1148-54. PubMed ID: 17342176
[TBL] [Abstract][Full Text] [Related]
16. Update on treatment of immunoglobulin A nephropathy.
Zhang YM; Zhang H
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():62-67. PubMed ID: 30298661
[TBL] [Abstract][Full Text] [Related]
17. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
Moura IC; Arcos-Fajardo M; Gdoura A; Leroy V; Sadaka C; Mahlaoui N; Lepelletier Y; Vrtovsnik F; Haddad E; Benhamou M; Monteiro RC
J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
[TBL] [Abstract][Full Text] [Related]
18. Mesangial nephropathy and anti-synthetase syndrome: An odd association.
Morales E; Rabasco C; Panizo N; Gutierrez E; Martinez MA; Toldos O; Praga M
Nefrologia; 2015; 35(4):415-7. PubMed ID: 26306954
[No Abstract] [Full Text] [Related]
19. Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.
Placzek WJ; Yanagawa H; Makita Y; Renfrow MB; Julian BA; Rizk DV; Suzuki Y; Novak J; Suzuki H
PLoS One; 2018; 13(1):e0190967. PubMed ID: 29324897
[TBL] [Abstract][Full Text] [Related]
20. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.
Yoshikawa N; Ito H; Sakai T; Takekoshi Y; Honda M; Awazu M; Ito K; Iitaka K; Koitabashi Y; Yamaoka K; Nakagawa K; Nakamura H; Matsuyama S; Seino Y; Takeda N; Hattori S; Ninomiya M
J Am Soc Nephrol; 1999 Jan; 10(1):101-9. PubMed ID: 9890315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
